Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
180-Day Exclusivity Changes Pushed In Biden’s Budget Proposal
Mar 31 2022
•
By
Derrick Gingery
The FDA still wants to crack down on generic exclusivity "parking." • Source: Nielsen Hobbs; the Pink Sheet | Alamy, Shutterstock images
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics